MX2011007602A - Composiciones de peptidos para el tratamiento y diagnostico de la fiebre por virus dengue. - Google Patents

Composiciones de peptidos para el tratamiento y diagnostico de la fiebre por virus dengue.

Info

Publication number
MX2011007602A
MX2011007602A MX2011007602A MX2011007602A MX2011007602A MX 2011007602 A MX2011007602 A MX 2011007602A MX 2011007602 A MX2011007602 A MX 2011007602A MX 2011007602 A MX2011007602 A MX 2011007602A MX 2011007602 A MX2011007602 A MX 2011007602A
Authority
MX
Mexico
Prior art keywords
diagnosing
treating
dengue virus
peptide composition
fever caused
Prior art date
Application number
MX2011007602A
Other languages
English (en)
Other versions
MX350236B (es
Inventor
Roberto Manuel Cedillo Rivera
Gilma Guadalupe Sanchez Burgos
Eric Olivier Dumontiel
Original Assignee
Inst Mexicano Del Seguro Social
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Mexicano Del Seguro Social filed Critical Inst Mexicano Del Seguro Social
Priority to MX2011007602A priority Critical patent/MX350236B/es
Publication of MX2011007602A publication Critical patent/MX2011007602A/es
Publication of MX350236B publication Critical patent/MX350236B/es

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a composiciones de vacuna y tratamiento para la fiebre por dengue, así como a un equipo de diagnóstico para la fiebre del dengue. Dichas composiciones y equipo de diagnóstico se caracterizan por comprender péptidos inmunogénicos de virus dengue obtenidos mediante bioinformática.
MX2011007602A 2011-07-15 2011-07-15 Composiciones de peptidos para el tratamiento y diagnostico de la fiebre por virus del dengue. MX350236B (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2011007602A MX350236B (es) 2011-07-15 2011-07-15 Composiciones de peptidos para el tratamiento y diagnostico de la fiebre por virus del dengue.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011007602A MX350236B (es) 2011-07-15 2011-07-15 Composiciones de peptidos para el tratamiento y diagnostico de la fiebre por virus del dengue.

Publications (2)

Publication Number Publication Date
MX2011007602A true MX2011007602A (es) 2013-01-31
MX350236B MX350236B (es) 2017-08-31

Family

ID=48195107

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007602A MX350236B (es) 2011-07-15 2011-07-15 Composiciones de peptidos para el tratamiento y diagnostico de la fiebre por virus del dengue.

Country Status (1)

Country Link
MX (1) MX350236B (es)

Also Published As

Publication number Publication date
MX350236B (es) 2017-08-31

Similar Documents

Publication Publication Date Title
MX2019000586A (es) Virus adenoasociados (aav) sflt-1 para usarse en el tratamiento de degeneración macular relacionada con la edad (amd).
NL301223I2 (nl) Dengue tetravalent vaccin (levend, verzwakt): Denguevirus serotype 1 (levend, verzwakt) waarin genen van serotypespecifieke oppervlakte-eiwitten in dengue type-2 basis zijn ontworpen Denguevirus serotype 2 (levend, verzwakt) Denguevirus serotype 3 (levend, verzwakt) waarin genen van serotypespecifieke oppervlakte-eiwitten in dengue type-2 basis zijn ontworpen Denguevirus serotype 4 (levend, verzwakt) waarin genen van serotypespecifieke oppervlakte-eiwitten in dengue type-2 basis zijn ontworpen
EA201992133A1 (ru) Производные пиперидино-пиримидина для лечения вирусных инфекций
UA115231C2 (uk) Сполуки імідазопіролідинонів
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
MY168959A (en) Vaccine compositions for the prevention of dengue virus infection
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
NZ708144A (en) Recombinant adenoviruses and use thereof
PH12014502875A1 (en) Vaccine compositions for prevention against dengue virus infection
MX2016007063A (es) Peptidos terapeuticos.
MX2016003419A (es) Metodos y composiciones para sindrome respiratorio coronavirus de oriente medio (mers-cov) inmunogenico.
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
MX2013004061A (es) Analogos de ciclosporina.
EA201591888A1 (ru) Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов
EA201001820A1 (ru) Новые иммуноадъювантные соединения на основе флагеллина и их применение
MY169328A (en) Compositions for the treatment of dry eye
EA201370018A1 (ru) Составы рифаксимина и их применение
EA201491617A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201590667A1 (ru) Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
EA201792407A3 (ru) Композиции, содержащие буфер, составы вакцин, которые содержат композиции, содержащие буфер, и пути их применения
WO2015095735A3 (en) Vaccine compositions and uses thereof
EA201590491A1 (ru) Иммуногенная композиция
NZ703597A (en) Mutant fragments of ospa and methods and uses relating thereto
MX2013004062A (es) Analogos de ciclosporina.

Legal Events

Date Code Title Description
FG Grant or registration